Veteran fund manager points to glaring problem with stocks after rally
Stock market rally defies gravity, leaves many behind
The S&P 500's seemingly unrelenting climb from early April into July 2025 has left many investors shaking their heads.
This spring, the stock market lost nearly 20% of its value amid a flurry of newly announced tariffs. Worry that tariff-induced inflation would derail the economy, causing stagflation or recession, was rampant.
That worry remains, given that tariffs remain much higher than one year ago and economic data show that the U.S. economy is slowing. Yet stocks have brushed aside concerns since April 9, when President Donald Trump paused many reciprocal tariffs, clearing the way for trade deals.As a result, many investors expecting a reckoning have been left stuck on the sidelines, wondering if it's too late to buy.
Veteran hedge fund manager Doug Kass understands the feeling. Kass has been professionally managing money since the 1970s, and his long career includes a stint as the research director for Leon Cooperman's Omega Advisors, one of the most famous hedge funds ever.
This week, Kass discussed the recent stock market rally and its causes and delivered a stern message on risks every investor should consider after the S&P 500's record-setting run.
The stock market's gains have been driven by animal spirits, speculation, and computer algos
It used to be that humans on major exchanges, like the New York Stock Exchange, executed trades for other humans.
Quaint, right?
Now, the stock market's inevitable pops and drops are at the whim of computer programmers who have designed programs to exploit every tick higher or lower, and products developed by money-hungry Wall Street firms, like short-term options, that are designed to capitalize best on greed and fear."In the steel cage match since the market's lows in April, the bulls have been virtually unbeatable — like Muhammad Ali and Hulk Hogan," wrote Doug Kass in a post on TheStreet Pro. "But, as we all know, all the WWF matches were fixed — a feeling that the bears have developed over the last three months as retail, zero days to expiration option traders, and volatility-controlled funds have aggressively bought every dip, contributing to the generation of animal spirits and fear of missing out."
The combination has led to momentum fueling momentum for momentum's sake.
Computers trading with computers and speculators looking for quick gains from the options market have created a self-fulfilling cycle of upside, creating massive fear of missing out, or FOMO, for those who sold during the downturn or held off on new investments, hoping for a better entry point.
The gains have been particularly eye-popping for risky stocks, particularly within emerging industries like crypto, artificial intelligence, space, and quantum computing.
Circle Internet () , a stablecoin cryptocurrency player, has gained 132% since its June IPO. CoreWeave () , an AI cloud computing company, is up 165% since April 8. Rocket Lab () , which sends light payloads into low orbit, has gained 188% since its early April lows. And Quantum Computing () is up 278% since its bottom in March.
What's one thing those companies share in common? None has turned a profit yet.
Problems with U.S. economy may not be ignored forever
The S&P 500's 24% gain in 2024 was built on the back of surging spending on artificial intelligence, the promise of earnings growth associated with using AI to streamline business practices and procedures, and the prospect of lower interest rates, thanks to the Federal Reserve shifting from hawkish to dovish monetary policy.
So far, the Fed has yet to cut rates in 2025, despite lowering rates by 1% into the end of 2024, creating a headwind. AI spending remains robust, given that Alphabet recently increased its capital expenditure outlook this year to $85 billion from $75 billion.
Still, cracks have appeared in the economy that didn't exist last year:
Layoffs totaled 247,256 in Q2, according to Challenger, Gray, & Christmas, the most since the Covid pandemic closed businesses in 2020.
The unemployment rate is 4.1%, up from 3.4% in 2023.
The World Bank estimates U.S. GDP growth will be just 1.4% in 2025, down from 2.8% last year.
And let's not forget tariffs, which, while likely to be less than feared in April, still represent a massive tax hike.
That economic backdrop is problematic for stocks, especially following their big move higher.
"The level of delusion (that tariffs will have no inflationary impact) is now beyond the pale. It simply seems the administration is following the Roy Cohen strategy on inflation and tariffs — in that if you repeat 'The Big Lie' enough (that tariffs aren't raising prices), people will come to believe it," opined Kass.
Stock market valuation could create a headwind for stocks
So far, markets have ignored the inflationary threat, assuming trade deals will soften the blow and corporations can make up any margin hit either by benefiting from a weaker US Dollar on currency conversion or by cutting costs.
Indeed, those betting the U.S. economy will sidestep the worst-case scenario — slow growth with inflation or even recession — have profited largely.However, valuations on many stocks have surged, and as a result, the S&P 500's forward one-year price to earnings ratio is 22.4, according to FactSet.
A P/E ratio that high has historically depressed forward stock market returns. Absent a significant uptick in earnings estimates, now largely expected, stocks could take a breather.
"My recent complete sales of numerous longs (in housing, financials, private equity and selected technology) have resulted in an expanded cash war chest, which I want in the time ahead," noted Kass on July 23. "I see about 5x more risk than reward, and I see no "margin of safety."
Of course, stocks can go higher and lower than many believe possible, which is why, as John Maynard Keynes said, "The market can remain irrational longer than you can remain solvent."
Sitting in cash hasn't been a winning strategy lately, something Kass concedes.
"I am often wrong and always in doubt," wrote Kass. Nevertheless, he says, "The fact is, though many in the business media say the opposite, earnings estimates are dropping and not increasing — as equities climb."
If so, having some cash to take advantage of any weakness may pan out yet.Veteran fund manager points to glaring problem with stocks after rally first appeared on TheStreet on Jul 26, 2025
This story was originally reported by TheStreet on Jul 26, 2025, where it first appeared.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Yankees are paying 3 players a combined $43.8 million to not play for them
The New York Yankees have always been known for having a lot of money. They may not be the richest franchise in baseball anymore, though. The New York Mets and Los Angeles Dodgers seem to be shelling out even more dough. But the Yankees have one financial flex going for them, if it can be called a flex. And it's this: They're currently paying three players a combined $43.8 million not to play for them. Those three guys are DJ LeMahieu, Aaron Hicks and Marcus Stroman. The number works out to $43,785,714, to be exact. MORE: Cubs' Matthew Boyd has mastered the balk pickoff move Baseball contracts, unlike many of those in other professional sports, are fully guaranteed upon signing. That means when the Yankees get rid of Hicks in the past, or LeMahieu and Stroman this season, they're still owed their money. Stroman was just released after his last start, a bit of a surprise move. And like Stroman, both Hicks and LeMahieu were better before getting their latest Yankees contracts than they were afterward. MORE: Red Sox leapfrog the Yankees in the standings for first time since March As a big-market club with deep pockets, the Yankees can afford to make mistakes in contracts every once in a while. It's still not ideal that these mistakes are costing more than $43 million to guys not currently wearing the pinstripes in any form. The $43 million might not come in handy now, but it could matter greatly down the line. That's very real money that the Yankees won't have from production they aren't getting anyway. MORE MLB NEWS: White Sox batters have turned into 1927 Yankees Steven Kwan shows kindness on the most stressful day of his MLB career Marlins' Jakob Marsee starts his MLB career in a way no one ever has Rockies' Warming Bernabel is red hot Oneil Cruz makes one of the best throws in MLB history Red Sox phenom Roman Anthony makes MLB history not done since Elmer Valo in 1940
Yahoo
34 minutes ago
- Yahoo
Elis: Disclosure of trading in own shares occured from July 28 to August 1, 2025
Disclosure of trading in own shares occurred from July 28 to August 1, 2025 Saint-Cloud, August 4, 2025 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from July 28 to August 1, 2025 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025 and announced on March 6, 2025: Aggregated presentation: Issuer name Issuer code(LEI) Transaction date ISIN Code Daily total Volume (in number of shares) Daily weighted average price of shares acquired (in euros) Platform (MIC Code) ELIS SA 969500UX71LCE8MAY492 07/28/2025 FR0012435121 20,000 25.0413 XPAR ELIS SA 969500UX71LCE8MAY492 07/29/2025 FR0012435121 24,000 25.0691 XPAR ELIS SA 969500UX71LCE8MAY492 07/30/2025 FR0012435121 32,000 24.8650 XPAR ELIS SA 969500UX71LCE8MAY492 07/30/2025 FR0012435121 9,000 24.7547 DXE ELIS SA 969500UX71LCE8MAY492 07/31/2025 FR0012435121 32,310 24.0257 XPAR ELIS SA 969500UX71LCE8MAY492 07/31/2025 FR0012435121 25,520 24.0674 DXE ELIS SA 969500UX71LCE8MAY492 07/31/2025 FR0012435121 6,000 23.8797 TQE ELIS SA 969500UX71LCE8MAY492 07/31/2025 FR0012435121 4,500 23.9301 AQE ELIS SA 969500UX71LCE8MAY492 08/01/2025 FR0012435121 22,627 24.3029 XPAR ELIS SA 969500UX71LCE8MAY492 08/01/2025 FR0012435121 5,711 24.1992 DXE Total 181,668 24.4979 The purpose of the own shares purchase operations is (i) to cover maturing performance share plans and to allocate free shares to employees as part of the contribution to the Elis for All 2025 international employee shareholding plan, and (ii) to be cancelled in accordance with the 26th resolution of the Combined General Meeting of May 22, 2025. Contacts Nicolas BuronDirector of Investor Relations, Financing & TreasuryPhone: + 33 (0)1 75 49 98 30 - Charline LefaucheuxInvestor Relations Phone: + 33 (0)1 75 49 98 15 - Attachment Elis - Disclosure of trading in own shares occured from July 28 to August 1, 2025
Yahoo
34 minutes ago
- Yahoo
European Growth Companies With High Insider Ownership August 2025
Amid recent market turbulence, European stocks have faced challenges, with the STOXX Europe 600 Index dropping by 2.57% due to dissatisfaction over a trade agreement framework between the U.S. and EU. In this environment of cautious economic sentiment and modest growth rates, companies with high insider ownership can offer a unique appeal as they often reflect strong confidence from those who know the business best, potentially aligning interests with shareholders and fostering long-term growth strategies. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 44.2% MedinCell (ENXTPA:MEDCL) 13.9% 94% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 65% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. We're going to check out a few of the best picks from our screener tool. Ercros Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ercros, S.A. is a Spanish company that manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals with a market cap of €283 million. Operations: The company's revenue is derived from pharmaceuticals (€64.49 million), chlorine derivatives (€378.78 million), and intermediate chemicals (€186.56 million). Insider Ownership: 15.9% Ercros is forecast to achieve above-average market profit growth over the next three years, despite recent financial challenges. The company reported a net loss of €29.27 million for the first half of 2025, with revenue declining to €358.55 million from the previous year. While Ercros' revenue growth is expected to surpass the Spanish market rate, its dividend coverage remains weak and debt coverage by operating cash flow is inadequate. The stock trades at a good relative value compared to peers. Navigate through the intricacies of Ercros with our comprehensive analyst estimates report here. The analysis detailed in our Ercros valuation report hints at an deflated share price compared to its estimated value. Edda Wind Simply Wall St Growth Rating: ★★★★★☆ Overview: Edda Wind ASA develops, builds, owns, operates, and charters service operation vessels (SOVs) and commissioning service operation vessels (CSOVs) for offshore wind farms globally, with a market cap of NOK2.94 billion. Operations: The company's revenue segment is primarily derived from its Offshore Wind Segment, totaling €79.42 million. Insider Ownership: 29.7% Edda Wind's growth prospects are underpinned by a forecasted earnings increase of 94.6% annually, outpacing the Norwegian market. Despite a decline in profit margins from 11.5% to 2.3%, revenue is expected to grow significantly at 33.1% per year, surpassing the market average. Recent M&A activity resulted in Geveran Trading Co., Ltd., Wilhelmsen New Energy AS, and EPS Ventures Ltd acquiring full ownership, potentially leading to strategic shifts as they plan to de-list the company from Oslo Stock Exchange. Click here and access our complete growth analysis report to understand the dynamics of Edda Wind. The valuation report we've compiled suggests that Edda Wind's current price could be inflated. Smart Eye Simply Wall St Growth Rating: ★★★★★☆ Overview: Smart Eye AB (publ) specializes in developing AI technology solutions that analyze and predict human behavior, serving markets in the Nordics, Europe, North America, Asia, and globally, with a market cap of SEK2.48 billion. Operations: Smart Eye AB (publ) generates revenue through its segments in Behavioral Research, contributing SEK255.40 million, and Automotive Solutions, contributing SEK103.65 million. Insider Ownership: 15.2% Smart Eye is poised for substantial growth, with revenue expected to expand by 42.6% annually, surpassing the Swedish market's average. Recent product innovations like AI ONE and an upgraded AIS system highlight its commitment to advanced driver monitoring solutions. Despite reporting a net loss of SEK 55.1 million in Q1 2025, Smart Eye's forecasted profitability within three years indicates strong potential. Insider ownership remains significant, reflecting confidence in its strategic direction and technological advancements. Click to explore a detailed breakdown of our findings in Smart Eye's earnings growth report. According our valuation report, there's an indication that Smart Eye's share price might be on the expensive side. Key Takeaways Access the full spectrum of 214 Fast Growing European Companies With High Insider Ownership by clicking on this link. Curious About Other Options? These 19 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include BME:ECR OB:EWIND and OM:SEYE. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data